Synergistic effect of aurintricarboxylic acid and triflavin in a photochemically induced thrombosis model in rats

European Journal of Pharmacology

Volumn 312, Issue 1, 1996, Pages 69-73

  Hisamichi, Nami ^a   Kawasaki, Tomihisa ^a   Suzuki, Ken Ichi ^a   Kaku, Seiji ^a   Sakai, Yumiko ^a   Taniuchi, Yuta ^a   Sato, Kazuo ^a   Inagaki, Osamu ^a   Tomioka, Kenichi ^a   Yanagisawa, Isao ^a   Takenaka, Toichi ^a   Yanagi, Kennichi ^b   Ohshima, Norio ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Aurintricarboxylic acid; Glycoprotein IIb IIIa; Photochemically induced thrombosis; Triflavin; Von Willebrand factor

Indexed keywords

AURINTRICARBOXYLIC ACID; DISINTEGRIN; TRIFLAVIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOGENESIS; THROMBOSIS;

EID: 0030593751     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00547-X     Document Type: Article

References (32)

1. Bernat A., A. Lale and J.-M. Herbert, 1994, Aurin tricarboxylic acid inhibits experimental venous thrombosis, Thromb. Res. 74, 617.
2. Carteaux, J.-P., B. Steiner and S. Roux, 1993, Ro 44-9883, a new non-peptidic GPIIb-IIIa antagonist prevents platelet loss in a guinea pig model of extracorporeal circulation, Thromb. Haemost. 70, 817.
3. Coller, B.S., J.D. Folts, L.E. Scudder and S.R. Smith, 1986, Antilhrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model, Blood 68, 783.
4. Coller, B.S., J.D. Folts, S.R. Smith, L.E. Scudder and R. Jordan, 1989, Abolition of in vivo platelet thrombus formation in primales with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors, Circulation 80, 1766.
5. Davies, M.J., A.C. Thomas, P.A. Knapman and J.R. Hangartner, 1986, Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death, Circulation 73, 418.
6. Fujimura Y., Y. Ikeda, S. Miura, E. Yoshida, H. Shima, S. Nishida, M. Suzuki, K. Titani, Y. Taniuchi and T. Kawasaki, 1995, Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib, Thromb. Haemost. 74, 743.
7. Huang, T.-F., J.-R. Sheu and C.-M. Teng, 1991a, A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom, Biochem. J. 277, 351.
8. Huang, T.-F., J.-R. Sheu, C.-M. Teng, S.-W. Chen and C.-S. Liu, 1991b, Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein Hb-IIIa complex, J. Biochem. 109, 328.
9. Ikeda, Y., M. Handa, K. Kawano, T. Kamata, M. Murata, Y. Araki, H. Anbo, Y. Kawai, K. Watanabe, I. Itagaki, K. Sakai and Z.M. Ruggeri, 1991, The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress, J. Clin. Invest. 87, 1234.
10. Kaku, S., T. Kawasaki, Y. Sakai, Y. Taniuchi, S. Yano, K. Suzuki, C. Terazaki, K. Kawamura, Y. Masuho, N. Satoh, T. Takenaka, K. Yanagi and N. Ohshima, 1995. Antithrombotic effect of a humanized anti-GPIIb/IIIa monoclonal antibody, YM207, in a photochemically induced thrombosis model in monkeys, Eur. J. Pharmacol., 279, 115.
11. Kawasaki, T., S. Kaku, T. Kohinata, Y. Sakai, Y. Taniuchi, K. Kawamura, S. Yano, T. Takenaka and Y. Fujimura, 1994a, Inhibition by aurintricarboxylic acid of von Willebrand factor binding to platelet GPIb, platelet retention, and thrombus formation in vivo, Am. J. Hematol. 47, 6.
12. Kawasaki, T., S. Kaku, T. Takenaka, K. Yanagi and N. Ohshima, 1994b, Thrombolytic activity of YM866, a novel modified tissue-type plasminogen activator, in a photochemically induced platelet-rich thrombosis model, J. Cardiovasc. Pharmacol. 23, 884.
13. Kawasaki, T., Y. Taniuchi, N. Hisamichi, Y. Fujimura, M. Suzuki, K. Titani, Y. Sakai, S. Kaku, N. Satoh, T. Takenaka, M. Handa and Y. Sawai, 1995, Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein Ib and inhibits von Willebrand factor-dependent shear-induced platelet aggregation, Biochem. J. 308, 947.
14. Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193, 265.
15. Nicholson, N.S., S.G. Panzer-Knodle, A.K. Salyers, B.B. Taite, J.A. Szalony, N.F. Haas, L.W. King, J.A. Zablocki, B.T. Keller, K. Broschat, V.W. Engleman, M. Herin, P. Jacqmin and L.P. Feigen, 1995, SC-54684A: an orally active inhibitor of platelet aggregation, Circulation 91, 403.
16. Peerlinck, K., I.D. Lepeleire, M. Goldberg, D. Farrell, J. Barrett, E. Hand, D. Panebianco, H. Deckmyn, J. Vermylen and J. Arnout, 1993, MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man, Circulation 88, 1512.
17. Peng, M., W. Lu, L. Beviglia, S. Niewiarowski and E.P. Kirby, 1993, Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib, Blood 81, 2321.
18. Phillips, M.D., J.L. Moake, L. Nalasco and N. Turner, 1988, Aurintricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets, Blood 72, 1898.
19. Pidard, P., R.R. Montgomery, J.S. Bennett and T.J. Kunicki, 1983, Interaction of AP2, a monoclonal antibody specific for the human platelet glycoprotein IIb/IIIa complex, with intact platelets, J. Biol. Chem. 258, 12582.
20. Plow, E.F. and M.H. Ginsberg, 1988, Cellular adhesion: GPIIb/IIIa as a prototypic adhesion receptor, Prog. Hemost. Thromb. 9, 117.
21. Plow, E.F., M.D. Pierschbacher, E. Ruoslahti, G.A. Marguerie and M.H. Ginsberg, 1985, The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets, Proc. Natl. Acad. Sci. USA 82, 8057.
22. Ramjit, D.R., J.J. Lynch Jr., G.R. Sitko, M.J. Mellott, M.A. Holahan, I.I. Stabilito, M.T. Stranieri, G. Zhang, R.J. Lynch, P.D. Manno, C.T-C. Chang, R.F. Nutt, S.F. Brady, D.F. Veber, P.S. Anderson, R.J. Shebuski, P.A. Friedman and R.J. Gould, 1993, Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in a canine model of thrombosis, J. Pharmacol. Exp. Ther. 266, 1501.
23. Rosenblum, W.I. and F. El-Sabban, 1977, Platelet aggregation in the cerebral microcirculation. Effect of aspirin and other agents, Circ. Res. 40, 320.
24. Sakariassen, K.S., P.A. Bolhuis and J.J. Sixma, 1987, Human blood platelet adhesion to artery subendothelium is mediated by factor VIII/von Willebrand factor bound to the subendothelium. Nature (London) 279, 636.
25. Sato, M. and N. Ohshima, 1984, Platelet thrombus induced in vivo by filtered light and fluorescent dye in mesenteric microvessels of the rat, Thromb. Res. 35, 319.
26. Sato, M., T. Natori and N. Ohshima, 1987, Effects of scavengers of active oxygens on the platelet thrombus formation in microvessels induced by photochemical reaction, in: Microcirculation Annual, eds. M. Tsuchiya et al. (Nihon-Igakukan, Tokyo) p. 135.
27. Scarborough, R.M., J.W. Rose, M.A. Hsu, D.R. Phillips, V.A. Fried, A.M. Campbell, L. Nannizzi and I.F. Charo, 1991, Barbourin, a GPIIb/IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri, J. Biol. Chem. 266, 9359.
28. Sheu, J.-R., S.-H. Chao, M.-H. Yen and T.-F. Huang, 1994, In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice, Thromb. Haemost. 72, 617.
29. Strony, J., M. Phillips, D. Brands, J. Moake and D. Adelman, 1990, Aurintricarboxylic cid in a canine model of coronary artery thrombosis, Circulation 81, 1106.
30. Taniuchi, Y., T. Kawasaki, Y. Fujimura, M. Suzuki, K. Titani, Y. Sakai, S. Kaku, N. Hisamichi, N. Satoh, T. Takenaka, M. Handa and Y. Sawai, 1995, Flavocetin-A and -B, two high molecular mass glycoprotein Ib binding proteins with high affinity purified from Trimeresurus flavoviridis venom, inhibit platelet aggregation at high shear stress, Biochim. Biophys. Acta 1244, 331.
31. Yao, S.-K., J.C. Ober, L.I. Garfinkel, Y. Hagay, N. Ezov, J.J. Ferguson, H.V. Anderson, A. Panet, M. Gorecki, L.M. Buja and J.T. Willerson, 1994, Blockade of platelet membrane glycoprotein Ib receptors delays intracoronary thrombogenesis, enhances thrombolysis, and delays coronary artery reocclusion in dogs. Circulation 89, 2822.
32. Yasuda, T., H.K. Gold, R.C. Leinbach, H. Yaoita, J.T. Fallon, L. Guerrero, M.A. Napier, S. Bunting and D. Collen, 1991, Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation, Circulation 83, 1038.